Inactivation of the 5-HT7 Receptor Partially Blocks Phencyclidine-Induced Disruption of Prepulse Inhibition
- 1 January 2008
- journal article
- Published by Elsevier BV in Biological Psychiatry
- Vol. 63 (1), 98-105
- https://doi.org/10.1016/j.biopsych.2006.12.011
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Effect of the selective 5-HT7 receptor antagonist SB 269970 in animal models of anxiety and depressionNeuropharmacology, 2006
- Positive Association of the Serotonin 5-HT7 Receptor Gene with Schizophrenia in a Japanese PopulationNeuropsychopharmacology, 2005
- Genetic knockout and pharmacological blockade studies of the 5-HT7 receptor suggest therapeutic potential in depressionNeuropharmacology, 2005
- Functional, molecular and pharmacological advances in 5-HT7 receptor researchTrends in Pharmacological Sciences, 2004
- SB‐656104‐A, a novel selective 5‐HT7 receptor antagonist, modulates REM sleep in ratsBritish Journal of Pharmacology, 2003
- Mouse genetic models for prepulse inhibition: an early reviewMolecular Psychiatry, 2002
- Characterization of SB‐269970‐A, a selective 5‐HT7 receptor antagonistBritish Journal of Pharmacology, 2000
- Neurobiological similarities in depression and drug dependence: A self-medication hypothesisNeuropsychopharmacology, 1998
- Effects of phencyclidine and phencyclidine biologs on sensorimotor gating in the rat*1Neuropsychopharmacology, 1989
- Development of dispositional tolerance to phencyclidine by osmotic minipump in the mouseJournal of Pharmacological Methods, 1982